Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07527390) titled 'CANagliflozin In DIALysis Patients' on April 7.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: University Medical Center Groningen
Condition:
Dialysis
Chronic Kidney Disease (Stages 4 and 5)
Intervention:
Drug: Invokana 300 mg and 100 mg tablet
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: June 1, 2026
Target Sample Size: 10
Countries of Recruitment:
Netherlands
To know more, visit https://clinicaltrials.gov/study/NCT07527390
Published by HT D...